IHT Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $782K | Buy |
11,325
+5,320
| +89% | +$367K | 0.02% | 569 |
|
|
2025
Q1 | $417K | Sell |
6,005
-1,187
| -17% | -$82.4K | 0.01% | 731 |
|
|
2024
Q4 | $619K | Sell |
7,192
-4,119
| -36% | -$354K | 0.02% | 617 |
|
|
2024
Q3 | $1.34M | Buy |
11,311
+3,228
| +40% | +$383K | 0.04% | 420 |
|
|
2024
Q2 | $1.15M | Buy |
8,083
+2,470
| +44% | +$352K | 0.04% | 383 |
|
|
2024
Q1 | $721K | Buy |
5,613
+239
| +4% | +$30.7K | 0.03% | 520 |
|
|
2023
Q4 | $556K | Sell |
5,374
-343
| -6% | -$35.5K | 0.02% | 563 |
|
|
2023
Q3 | $520K | Buy |
5,717
+485
| +9% | +$44.1K | 0.03% | 544 |
|
|
2023
Q2 | $423K | Buy |
5,232
+286
| +6% | +$23.1K | 0.02% | 596 |
|
|
2023
Q1 | $394K | Buy |
4,946
+208
| +4% | +$16.5K | 0.02% | 596 |
|
|
2022
Q4 | $321K | Buy |
4,738
+160
| +3% | +$10.8K | 0.02% | 634 |
|
|
2022
Q3 | $228K | Buy |
+4,578
| New | +$228K | 0.02% | 732 |
|
|
2018
Q2 | – | Sell |
-52
| Closed | -$1K | – | 1041 |
|
|
2018
Q1 | $1K | Sell |
52
-1,000
| -95% | -$19.2K | ﹤0.01% | 1611 |
|
|
2017
Q4 | $29K | Hold |
1,052
| – | – | 0.01% | 868 |
|
|
2017
Q3 | $26K | Sell |
1,052
-978
| -48% | -$24.2K | 0.01% | 695 |
|
|
2017
Q2 | $134 | Hold |
2,030
| – | – | 0.06% | 293 |
|
|
2017
Q1 | $36K | Buy |
2,030
+480
| +31% | +$8.51K | 0.02% | 502 |
|
|
2016
Q4 | $28K | Buy |
+1,550
| New | +$28K | 0.02% | 533 |
|